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R
egulators of G protein signaling (RGSs) bind to specific Ga subunits of heterotrimeric G proteins (Gabg) and accelerate the hydrolysis of Ga-bound guanosine triphosphate, thereby abrogating the signaling by G proteins (1) (2) (3) (4) . The mammalian Rgs2 protein regulates stress responses, translation, circadian rhythms, Ca 2+ channels, specific hormones, and cardiovascular homeostasis (3) (4) (5) (6) (7) (8) (9) (10) . Blood pressure-increasing vasoconstrictors such as norepinephrine and angiotensin II are upregulated by activated Ga q proteins, which are deactivated by Rgs2 (7). Both Rgs2 −/− and heterozygous Rgs2 +/− mice are strongly hypertensive (8, 9) . Human patients with decreased Rgs2 signaling are hypertensive as well (10) . In some hypertensive patients, one of two Rgs2 genes encodes Met-Leu-Rgs2 (ML-Rgs2), in which Gln at position 2 of wild-type MetGln-Rgs2 (MQ-Rgs2) is replaced by Leu. Another hypertension-associated Rgs2 mutant is Met-Arg-Rgs2 (MR-Rgs2) (10) . The Gln → Leu and Gln → Arg mutations are not detected in the general population (10) . All three Rgs2 proteins are up-regulated by a proteasome inhibitor, which suggests that they may be targeted by a proteasome-dependent proteolytic system (11) .
The N-end rule pathway recognizes proteins containing N-terminal (Nt) degradation signals called N-degrons, polyubiquitylates these proteins, and thereby causes their degradation by the proteasome ( fig. S1 ) (12) (13) (14) (15) (16) (17) (18) (19) (20) pathway mediates a broad range of biological functions ( fig. S1 ) (12) (13) (14) (15) (16) (17) (18) (19) (20) .
The N-end rule pathway consists of two branches. One branch, the Arg/N-end rule pathway, targets unacetylated destabilizing Nt residues (12, 14, 16) . The Nt residues Arg, Lys, His, Leu, Phe, Tyr, Trp, and Ile, as well as Nt-Met [if it is followed by a bulky hydrophobic (Ф) residue], are directly recognized by N-recognins (16) . In contrast, the unacetylated Asn, Gln, Asp, and Glu (as well as Cys, under some conditions) Nt residues are destabilizing, owing to their preliminary enzymatic modifications ( fig. S1D) .
The pathway's other branch, called the Ac/Nend rule pathway, targets proteins through their N a -terminally acetylated (Nt-acetylated) residues (fig. S1, A and C) (13, 15, 16) . Degrons and E3 ubiquitin ligases of the Ac/N-end rule pathway are called Ac/N-degrons and Ac/N-recognins, respectively. Approximately 90% of human proteins are cotranslationally and irreversibly Ntacetylated by ribosome-associated Nt-acetylases (21, 22) . (In contrast, acetylation of internal Lys residues is reversible and largely posttranslational.) Doa10, an ER membrane-embedded E3 ubiquitin ligase of the yeast Saccharomyces cerevisiae (23, 24) , functions as an Ac/N-recognin (13) . Not4, a cytosolic and nuclear E3, is another yeast Ac/Nrecognin (15) .
The Arg/N-end rule pathway is present in all examined eukaryotes, from fungi to mammals and plants ( fig. S1D) (12, 18, 19) . In contrast, the Ac/N-end rule pathway (fig. S1C) has been identified in S. cerevisiae (13, 15, 16) , but its presence in mammals and other multicellular eukaryotes has been conjectural so far.
We began by subjecting wild-type human MQRgs2 and its ML-Rgs2 mutant to cycloheximide (CHX) chases in yeast (13, 15, 16) . The C-terminally HA (hemagglutinin)-tagged MQ-Rgs2 ha was shortlived (t 1/2 ≈ 30 min) in wild-type yeast and was stabilized in both naa20D and doa10D cells, which lacked, respectively, the cognate NatB Nt-acetylase and the Doa10 Ac/N-recognin (13) (Fig. 1 , A and C, and figs. S1C and S2). Thus, in yeast, wild-type MQ-Rgs2 ha was degraded largely by the Ac/N-end rule pathway (13, 15, 16) .
The mutant human ML-Rgs2 ha was also shortlived in wild-type S. cerevisiae (t 1/2 < 15 min) and was partially stabilized in both naa30D and ubr1D cells, which lacked, respectively, the cognate NatC Nt-acetylase and the Ubr1 N-recognin of the Arg/Nend rule pathway (Fig. 1, B and D, and figs. S1C, S2, and S3, A and D). ML-Rgs2 ha was nearly completely stabilized in double-mutant naa30D ubr1D cells, including strongly elevated time-zero (prechase) levels of ML-Rgs2 ha (Fig. 1, B and D, and  fig. S3, A and D) .
Many cellular proteins are partially Nt-acetylated (21). Non-Nt-acetylated yeast MФ-type proteins are eliminated by the Arg/N-end rule pathway, whereas the Nt-acetylated counterparts of these proteins are destroyed by the Ac/N-end rule pathway (15, 16) . This dual-targeting pattern was also observed with human ML-Rgs2 ha (Fig. 1, B and D,  and fig. S3, A and D) . The contribution of the Ubr1 N-recognin to the degradation of ML-Rgs2 ha (Fig. 1B and fig. S3A ) indicated its incomplete Ntacetylation in S. cerevisiae, similarly to results with natural MФ-type yeast proteins (15, 16) . Both wild-type MQ-Rgs2 and the second hypertensionassociated mutant MR-Rgs2 were targeted (after their Nt-acetylation) solely by the Ac/N-end rule pathway, because the unacetylated Nt-Met followed by a non-Ф residue such as Gln or Arg is not recognized by the Arg/N-end rule pathway (in contrast to an MФ-type protein such as ML-Rgs2 ha ) ( fig. S1D) (16) .
Wild-type MQ-Rgs2 is a predicted substrate of the NatB Nt-acetylase ( fig. S2 ), in agreement with stabilization of MQ-Rgs2 ha in naa20D S. cerevisiae, which lack NatB (Fig. 1, A and C) . Using mass spectrometry (13), we analyzed the MQ-Rgs2 protein from human embryonic kidney (HEK) 293 cells, confirming its Nt-acetylation ( fig. S5A ).
Considerably unequal levels of transiently expressed MQ-Rgs2 ha , MR-Rgs2 ha , and ML-Rgs2 ha in human HeLa cells suggested their different stabilities (MQ > MR > ML) in these cells-an interpretation consistent with near-equal levels of the corresponding MX-Rgs2 mRNAs ( fig.  S4, C, F, and G) cells showed that MR-Rgs2 ha (t 1/2 < 8 min) and ML-Rgs2 ha (t 1/2 < 5 min) were shorter-lived than the also unstable wild-type MQ-Rgs2 ha (t 1/2 ≈ 15 min) (Fig. 1, E and F, and fig. S3 , B and E). The same (MQ > MR > ML) order of degradation rates was observed in 35 S pulse chases of MQRgs2 ha , MR-Rgs2 ha , and ML-Rgs2 ha (Fig. 1J and  fig. S4J ).
In contrast to Nt-acetylatable (and therefore short-lived) wild-type MQ-Rgs2 ha , the otherwise identical PQ-Rgs2 ha (Pro-Gln-Rgs2 ha ), generated cotranslationally from MPQ-Rgs2 ha , was neither Nt-acetylated nor recognized by the Arg/N-end rule pathway (figs. S1 and S2). PQRgs2 ha was long-lived in HeLa cells (Fig. 1, G and  H) . This result was an additional, conceptually independent piece of evidence for the targeting of Ac-MQ-Rgs2 ha by the Ac/N-end rule pathway ( fig. S1C) .
Remarkably, the exogenous (overexpressed) wild-type MQ-Rgs2 ha was much shorter-lived (t 1/2 ≈ 15 min) than the endogenous MQ-Rgs2 (t 1/2 ≈ 3 hours) in HeLa cells that did not overexpress MQ-Rgs2 ha (Fig. 1, E and F, Fig. 2B , and figs. S3, B and E, and S4, A and B). These results, with human cells, agreed with the recent demonstration of the biologically relevant conditionality of S. cerevisiae Ac/N-degrons (through their steric shielding in cognate protein complexes) (15) . Given this understanding with natural Ac/Nend rule substrates in yeast (15, 16, 25) , the present results ( fig. S4, A and B) are what one would expect if Ac-MQ-Rgs2, in human cells that do not overexpress it, can be (reversibly) shielded from the Ac/N-end rule pathway soon after Ntacetylation of MQ-Rgs2. This shielding would occur through formation of one or more physiologically relevant protective complexes between Ac-MQ-Rgs2 and its protein ligand(s). In contrast to the long half-life of the endogenous, "stoichiometrically" expressed MQ-Rgs2, its overexpression in HeLa cells would make the resulting "unprotectable" excess of Ac-MQRgs2 ha molecules vulnerable to destruction by the Ac/N-end rule pathway, thereby accounting for the large difference between the slowly degraded endogenous MQ-Rgs2 (in cells that do not overexpress MQ-Rgs2) and the short half-life of overexpressed MQ-Rgs2 ha ( fig. S4, A  and B) . Indeed, the short-lived MQ-Rgs2 was strongly stabilized by co-overexpression of one of its binding partners, the Ga q protein (Fig. 3,  A and B) .
A candidate Ac/N-recognin of the mammalian Ac/N-end rule pathway was Teb4, an ER membrane-embedded E3 ubiquitin ligase that polyubiquitylates proteins retrotranslocated from the ER. Teb4 is similar to the S. cerevisiae Doa10 Ac/N-recognin (13, 23, 24) . We found that human Teb4 was indeed an Ac/N-recognin:
1) Transiently expressed MQ-Rgs2 ha was upregulated by a proteasome inhibitor, whereas coexpression of human Teb4 (Teb4 3f ) and MQ-Rgs2 ha in HeLa cells down-regulated MQRgs2 ha (Fig. 2, A and F) . In addition, incrementally higher levels of Teb4 3f resulted in incrementally lower levels of endogenous MQRgs2 (Fig. 2G) .
2) The level of MQ-Rgs2 ha in HeLa cells was not decreased when MQ-Rgs2 ha was coexpressed with Teb4 C9A 3f , a missense mutant that is inactive as a ubiquitin ligase (24) (Fig. 2F) . Analogous assays with MR-Rgs2 ha and ML-Rgs2 ha gave similar results ( fig. S4, D and E) .
3) The in vivo polyubiquitylation of MQRgs2 ha in HeLa cells was increased by coexpression of Teb4 3f , but not by coexpression of the mutant Teb4 C9A 3f ( fig. S3F ). 4) In CHX chases, endogenous MQ-Rgs2 was stabilized by RNA interference (RNAi)-mediated knockdowns of either endogenous Teb4 E3 or endogenous cognate NatB Nt-acetylase (Fig. 2B  and fig. S4A ). Similar results were obtained with exogenous (overexpressed) MQ-Rgs2 ha , confirming the targeting of MQ-Rgs2 by Teb4 and indicating that this targeting required Nt-acetylation of MQ-Rgs2 by the NatB Nt-acetylase (Fig. 2B  and fig. S4, A and B) . In addition, overexpressed (hypertension-associated) MR-Rgs2 ha as well as the engineered MK-Rgs2 ha (which has a different basic residue at position 2) were stabilized by RNAi-based knockdown of Naa60, the catalytic subunit of cognate NatF Nt-acetylase (21, 22) , but these MX-Rgs2 ha proteins were not stabilized by knockdown of the noncognate NatB (Naa20) Nt-acetylase (Fig. 1I and fig. S4 , H and I).
5) Cross-linking and coimmunoprecipitation experiments indicated that Teb4 interacted with MQ-Rgs2 (more accurately, with Nt-acetylated Ac-MQ-Rgs2 ha , as shown below) (Fig. 2, H and I) . 6) PQ-Rgs2 ha was neither Nt-acetylated nor recognized by the Arg/N-end rule pathway and was a long-lived protein, in contrast to shortlived MQ-Rgs2 ha (Fig. 1, G and H, and fig. S1C ). In agreement with these in vivo results, Teb4 3f coimmunoprecipitated with MQ-Rgs2 ha (Ac-MQ-Rgs2 ha ) but not with PQ-Rgs2 ha (Fig. 2, H and I, and  fig. S3C ).
7) Glutathione S-transferase (GST) pull-down assays showed that Teb4 f interacted with Ac-MQRgs2 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] -GST (containing the first 10 residues of wild-type human Rgs2) but not with MQ-Rgs2 1-10 -GST or GST alone, indicating that the binding of Teb4 to Ac-MQ-Rgs2 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] -GST required its Nt-acetyl group (Fig. 2, C to E, and fig. S5B ).
By increasing the rate of deactivation of Ga q , Rgs2 can down-regulate Ga q -activated protein kinases, including the growth-promoting kinase Erk1/2 (3, 4). We asked whether the Teb4 Ac/Nrecognin could regulate the activation of Erk1/2 through the degradation of Nt-acetylated Ac-MQ-Rgs2. The Ga q -coupled M3 acetylcholine receptor was expressed in HeLa cells either alone or together with MQ-Rgs2 ha . By activating the M3 receptor-coupled Ga q , the agonist carbachol strongly increased the level of activated Erk1/2 [measured by detecting its phosphorylation by the "upstream" Mek1/Mek2 kinases (3, 4)].
As predicted by the model in which the Teb4-Rgs2 circuit regulates the activation of Erk1/2, this effect of carbachol on Erk1/2 was decreased in cells that also expressed MQ-Rgs2 ha and was further diminished upon RNAi-mediated knockdown of Teb4-a change that stabilized MQ-Rgs2 ha and thereby further elevated its level (Fig. 3C) .
Thus, wild-type human Ac-MQ-Rgs2, its hypertension-associated natural mutants Ac-MLRgs2 and Ac-MR-Rgs2, and its engineered mutant Ac-MK-Rgs2 are conditionally short-lived physiological substrates of the mammalian Ac/ N-end rule pathway, and the Teb4 ubiquitin ligase acts as an Ac/N-recognin of this pathway. Teb4 promotes G protein signaling by destroying the Ac-MX-Rgs2 proteins (X = Arg, Gln, Leu), which are targeted for degradation through their N a -terminal acetyl group. The faster degradation of ML-Rgs2 and MR-Rgs2 (relative to wild-type MQ-Rgs2) and their consequently lower levels can account, at least in part, for the hypertensive phenotypes of these mutants. The resulting understanding of Rgs2 with respect to the N-end rule pathway is summarized in fig. S6 .
Identification of Teb4 as an Ac/N-recognin of the mammalian Ac/N-end rule pathway suggests that some previously characterized substrates of Teb4, including specific transmembrane proteins [ (23, 24, 26) and references therein], may be recognized by Teb4 at least in part though their Ntacetylated Nt residues (Ac/N-degrons)-a testable proposition.
More than 30 human proteins contain an RGStype domain ( fig. S7) (3, 4) . The N-terminal Cys residue, a common feature of Rgs4, Rgs5, and Rgs16, can be oxidized in vivo by nitric oxide (NO) and oxygen. The resulting Nt-arginylation of oxidized Cys and the ensuing degradation of these RGSs by the Arg/N-end rule pathway mediate its previously described function as a sensor of NO and oxygen ( fig. S1D) [reviewed in (12, 18, 19) ]. Our study identified Rgs2 (MQ-Rgs2) as a different kind of N-end rule substrate, an Nt-acetylated one. Given their inferred N-terminal sequences, it is possible, indeed likely, that a number of other mammalian RGS proteins (in addition to Rgs2, Rgs4, Rgs5, and Rgs16) may also prove to be substrates of either the Ac/N-end rule pathway or the Arg/N-end rule pathway, or both of these proteolytic systems ( fig. S7 ).
Many cellular proteins contain Ac/N-degrons, having acquired them during synthesis (13) . These degradation signals, recognized by the Ac/Nend rule pathway, tend to be conditional, owing to their shielding in cognate protein complexes (15) . In addition, the Ac/N-end rule pathway and the Arg/N-end rule pathway are functionally complementary (16). It could therefore be possible to control the levels (and thus the activities) of many different proteins therapeutically, including Rgs2 and other RGSs, by modulating their Ac/N-degrons or specific components of the Ac/Nend rule pathway. fig. S3 for definitions of "100%" levels at zero time. (C) HeLa cells were subjected to RNAi either for a "scrambled" target or for Teb4. The M3 receptor was transiently expressed either alone or together with MQ-Rgs2 ha . The levels of indicated proteins, including the levels of either total Erk1/2 or the activated (specifically phosphorylated) Erk1/2p, were determined by SDS-PAGE and immunoblotting of cell extracts that had been prepared 10 min after treatment of cells with carbachol.
